Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies

Adv Ther. 2006 Jan-Feb;23(1):179-90. doi: 10.1007/BF02850359.


Extracts from the seed of the horse chestnut (Aesculus hippocastanum L.) have traditionally been used to treat patients with chronic venous insufficiency and to alleviate its associated symptoms, including lower leg swelling. The efficacy of preparations that contain horse chestnut seed extract (HCSE) is believed to be due largely to an inhibitory effect on the catalytic breakdown of capillary wall proteoglycans. Aesculaforce is a fresh plant HCSE that is available as an oral tincture, as tablets (20 mg or 50 mg), and as topical gel. Four clinical trials in patients with chronic venous insufficiency and 1 study in patients with varicose veins demonstrated the effectiveness of these preparations through the objective measure of reduction in lower leg edema and the subjective alleviation of leg pain, heaviness, and itching. Safe, well tolerated, and acceptable to patients, the fresh plant HCSE preparation Aesculaforce offers a real alternative in the treatment of patients with mild to moderate venous insufficiency.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aesculus*
  • Clinical Trials as Topic
  • Dosage Forms
  • Humans
  • Plant Extracts / therapeutic use
  • Seeds
  • Varicose Veins / drug therapy*
  • Venous Insufficiency / drug therapy*


  • Dosage Forms
  • Plant Extracts